Orange Book product · Generic (ANDA)
IOHEXOL
IOHEXOL
Generic (ANDA)ANDA 217737TE APRX AMNEAL
At a glance
Nov 13, 2025
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 13, 2025
7 mo ago
Today
Exclusivity ends · CGT
FDA marketing exclusivity
Jul 26, 2026
in 1 mo
Pharmaceutical detail
Active ingredient
IOHEXOL
Strength
64.7%
Dosage form
SOLUTION
Route
INJECTION, ORAL, RECTAL
TE code
AP
Application
ANDA 217737
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of IOHEXOL
Marketing exclusivity (1)
- CGTFDA marketing exclusivity
Jul 26, 2026
in 1 mo
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
